Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
A look into the complexities of managing advanced melanoma with BRAF–MEK inhibitors, highlighting a case study where treatment-induced toxic effects posed significant diagnostic and therapeutic challenges.
Hematology/Oncology January 22nd 2024
Oncology News Central (ONC)
In a recent comprehensive review, 15.2% of oncology conference abstracts used language that minimized treatment toxicities, potentially leading to misinformed treatment plans and impacting patient care. A call to action for clearer, data-driven communication in the field.
Hematology/Oncology January 8th 2024
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH